Ebola Vaccine Effectiveness. Effectiveness and Safety of a Heterologous Two-dose Ebola Vaccine in the DRC The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. An Ebola vaccine has proven to be 100 percent effective during test trials in Guinea.
World Health Organization WHO data shows the Merck vaccine has a 975 efficacy rate for those who are immunised compared to those who are not. Vaccinated individuals most commonly reported headache fatigue muscle pain and mild fever. An experimental vaccine against the Ebola virus is 975 percent effective at preventing the disease protecting well over 90000 people in the massive ongoing outbreak in the Democratic Republic.
During 20142015 trials of candidate vaccines for Ebola virus disease EVD were fast tracked in response to the unprecedented EVD epidemic in West Africa In March 2015 a phase 3 ring vaccination trial of a recombinant vesicular stomatitis virusZaire Ebola virus vaccine began in Guinea Interim trial results suggested that the vaccine could have a high level of efficacy in humans.
Listing a study does not mean it has been evaluated by the US. By contrast 16 cases were identified within the same time frame among 2041 people who did not receive the vaccine immediately. Ebola vaccine more than 97 effective in DRC outbreak The Ebola virus vaccine being used in the ongoing outbreak in the Democratic Republic of the Congo or DRC has been more than 97 effective. Marketing Authorization from the European Commission which is the executive arm of the European Union.